Merry C - Search Results

1

Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype.

McIlleron HM, Schomaker M, Ren Y, Sinxadi P, Nuttall JJ, Gous H, Moultrie H, Eley B, Merry C, Smith P, Haas DW, Maartens G. McIlleron HM, et al. Among authors: merry c. AIDS. 2013 Jul 31;27(12):1933-40. doi: 10.1097/qad.0b013e328360dbb4. AIDS. 2013. PMID: 24180002 Free PMC article.

2

Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis.

McIlleron H, Ren Y, Nuttall J, Fairlie L, Rabie H, Cotton M, Eley B, Meyers T, Smith PJ, Merry C, Maartens G. McIlleron H, et al. Among authors: merry c. Antivir Ther. 2011;16(3):417-21. doi: 10.3851/IMP1757. Antivir Ther. 2011. PMID: 21555825

3

The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy.

Decloedt EH, Maartens G, Smith P, Merry C, Bango F, McIlleron H. Decloedt EH, et al. Among authors: merry c. PLoS One. 2012;7(3):e32173. doi: 10.1371/journal.pone.0032173. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412856 Free PMC article.

4

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.

Oudijk JM, McIlleron H, Mulenga V, Chintu C, Merry C, Walker AS, Cook A, Gibb DM, Burger DM. Oudijk JM, et al. Among authors: merry c. AIDS. 2012 Jul 31;26(12):1523-8. doi: 10.1097/QAD.0b013e3283550e20. AIDS. 2012. PMID: 22546991 Clinical Trial.

5

Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets.

Decloedt EH, McIlleron H, Smith P, Merry C, Orrell C, Maartens G. Decloedt EH, et al. Among authors: merry c. Antimicrob Agents Chemother. 2011 Jul;55(7):3195-200. doi: 10.1128/AAC.01598-10. Epub 2011 May 2. Antimicrob Agents Chemother. 2011. PMID: 21537021 Free PMC article. Clinical Trial.

6

Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment.

Lamorde M, Byakika-Kibwika P, Mayito J, Nabukeera L, Ryan M, Hanpithakpong W, Lefèvre G, Back DJ, Khoo SH, Merry C. Lamorde M, et al. Among authors: merry c. AIDS. 2013 Mar 27;27(6):961-965. doi: 10.1097/QAD.0b013e32835cae3b. AIDS. 2013. PMID: 23698061

7

Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.

Merry C. Merry C. AIDS. 2001 May 25;15(8):1057-8. doi: 10.1097/00002030-200105250-00015. AIDS. 2001. PMID: 11399989 No abstract available.

8

The pharmacokinetics of combination therapy with nelfinavir plus nevirapine.

Merry C, Barry MG, Mulcahy F, Ryan M, Tjia JF, Halifax KL, Breckenridge AM, Back DJ. Merry C, et al. AIDS. 1998 Jul 9;12(10):1163-7. doi: 10.1097/00002030-199810000-00008. AIDS. 1998. PMID: 9677165

9

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients.

Merry C, Barry MG, Mulcahy F, Ryan M, Heavey J, Tjia JF, Gibbons SE, Breckenridge AM, Back DJ. Merry C, et al. AIDS. 1997 Mar 15;11(4):F29-33. doi: 10.1097/00002030-199704000-00001. AIDS. 1997. PMID: 9084785 Clinical Trial.

10

Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases.

Seden K, Khoo S, Back D, Prevatt N, Lamorde M, Byakika-Kibwika P, Mayito J, Ryan M, Merry C. Seden K, et al. Among authors: merry c. AIDS. 2013 Mar 13;27(5):675-86. doi: 10.1097/QAD.0b013e32835ca9b4. AIDS. 2013. PMID: 23719345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters